Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: TEICHOS LABORATORIES, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-30 to 2022-09-29
Current total value of award: $300000
Description: THE PROPOSAL, ENTITLED AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT, WAS SUBMITTED BY TEICHOS LABORATORIES, LLC, WEST LAFAYETTE, IN, WITH DR. LARRY CHRIS BLASZCZAK AS THE PI. THE O